Compare ProShares UltraShort Bloomberg Natural Gas ETF (KOLD) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ProShares UltraShort Bloomberg Natural Gas ETF vs Zimmer Biomet Holdings Inc — how do they compare? ProShares UltraShort Bloomberg Natural Gas ETF trades at $27.46, while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Zimmer Biomet Holdings Inc pays a 1.07% dividend while ProShares UltraShort Bloomberg Natural Gas ETF pays none. Which is the better fit depends on your goals.
| KOLD | ZBH | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $49.39 | $107.71 |
52-Week Low | $13.58 | $79.58 |
Market Cap | — | $17.36B |
Enterprise Value | — | $24.40B |
Dividend Yield | — | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
KOLD, a natural gas-focused ETF, trades at $28.25, up 4.01% today with strong bullish momentum from moving averages. Technical indicators show overbought conditions with RSI readings above 70, while ADX signals strong trend direction. Recent news highlights natural gas market volatility driven by weather forecasts and storage reports, with the EIA projecting record supply and demand for 2026.
The outlook remains tactical with heightened volatility expected from weather patterns and LNG export flows. Investment opportunities exist for short-term traders using KOLD as a hedging instrument, though overbought technicals and natural gas price sensitivity pose near-term risks. The ETF's performance is directly tied to natural gas futures price movements and market sentiment.
Zimmer Biomet (ZBH) trades at $88.92, down 2.41% on the day, with a bearish technical signal but strong fundamentals including a 70.03% gross margin and three consecutive quarterly EPS beats. Revenue grew to $8.23B in 2025, though net income margin compressed to 8.56%. The company announced a $1 billion share repurchase increase and expansion in India, while maintaining a dividend.
The stock offers a 10% upside to the $97.67 consensus price target, supported by value metrics and operational strength, but faces risks from rising debt levels and competitive pressures. Analyst sentiment is mixed with 40% buy ratings, suggesting cautious optimism amid near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ProShares UltraShort Bloomberg Natural Gas ETF
KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
